Melanoma inhibitor of apoptosis protein (ML-IAP) is a target for immune-mediated tumor destruction
暂无分享,去创建一个
Ken Jung | Joachim L. Schultze | Norman L. Letvin | Marcelo J. Kuroda | F. Stephen Hodi | J. Kutok | M. Mihm | F. Hodi | G. Dranoff | M. Kuroda | N. Letvin | R. Soiffer | J. Schultze | E. Greenfield | K. Hoar | R. Vonderheide | B. Maecker | Robert J. Soiffer | Glenn Dranoff | Jeffery L. Kutok | Robert H. Vonderheide | Jan C. Schmollinger | Kara M. Hoar | Britta Maecker | Edward A. Greenfield | Martin Mihm | J. Schmollinger | K. Jung
[1] J. Lieberman,et al. Granzymes A and B directly cleave lamins and disrupt the nuclear lamina during granule-mediated cytolysis , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[2] P. Chomez,et al. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. , 1991, Science.
[3] Philip J. R. Goulder,et al. Phenotypic Analysis of Antigen-Specific T Lymphocytes , 1996, Science.
[4] Lloyd J. Old,et al. New Paths in Human Cancer Serology , 1998, The Journal of experimental medicine.
[5] K. Kamiguchi,et al. An HLA-A24-restricted cytotoxic T lymphocyte epitope of a tumor-associated protein, survivin. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.
[6] E. Jaffee,et al. The collaboration of both humoral and cellular HER-2/neu-targeted immune responses is required for the complete eradication of HER-2/neu-expressing tumors. , 2001, Cancer research.
[7] R S Warren,et al. Chromosome arm 20q gains and other genomic alterations in colorectal cancer metastatic to liver, as analyzed by comparative genomic hybridization and fluorescence in situ hybridization , 1999, Genes, chromosomes & cancer.
[8] K. Sakaguchi,et al. Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[9] K. Parker,et al. Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains. , 1994, Journal of immunology.
[10] V. Dixit,et al. SMAC Negatively Regulates the Anti-apoptotic Activity of Melanoma Inhibitor of Apoptosis (ML-IAP)* , 2002, The Journal of Biological Chemistry.
[11] T. Hercend,et al. A natural cytotoxic T cell response in a spontaneously regressing human melanoma targets a neoantigen resulting from a somatic point mutation , 1999, European journal of immunology.
[12] C. Figdor,et al. Melanocyte lineage-specific antigen gp100 is recognized by melanoma- derived tumor-infiltrating lymphocytes , 1994, The Journal of experimental medicine.
[13] T. Ley,et al. DFF45/ICAD can be directly processed by granzyme B during the induction of apoptosis. , 2000, Immunity.
[14] N. Thornberry,et al. Granzyme B directly and efficiently cleaves several downstream caspase substrates: implications for CTL-induced apoptosis. , 1998, Immunity.
[15] D. Neuberg,et al. Vaccination with irradiated autologous melanoma cells engineered to secrete human granulocyte-macrophage colony-stimulating factor generates potent antitumor immunity in patients with metastatic melanoma. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[16] R. Mulligan,et al. A stable human-derived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[17] P. Bruggen,et al. Human tumor antigens recognized by T lymphocytes , 1996, The Journal of experimental medicine.
[18] Natale Cascinelli,et al. Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma , 1996, Cancer.
[19] J. Lin,et al. KIAP, a novel member of the inhibitor of apoptosis protein family. , 2000, Biochemical and biophysical research communications.
[20] D. B. Yehuda,et al. Two splicing variants of a new inhibitor of apoptosis gene with different biological properties and tissue distribution pattern , 2001, FEBS letters.
[21] M. Pfreundschuh,et al. Human neoplasms elicit multiple specific immune responses in the autologous host. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[22] P. Cresswell,et al. Impaired assembly and transport of HLA‐A and ‐B antigens in a mutant TxB cell hybrid. , 1986, The EMBO journal.
[23] A. Halpern,et al. Model predicting survival in stage I melanoma based on tumor progression. , 1989, Journal of the National Cancer Institute.
[24] L K Miller,et al. An exegesis of IAPs: salvation and surprises from BIR motifs. , 1999, Trends in cell biology.
[25] J. Becker,et al. Identification of a cytotoxic T lymphocyte response to the apoptosis inhibitor protein survivin in cancer patients. , 2001, Cancer research.
[26] Jongdae Lee,et al. IAP Suppression of Apoptosis Involves Distinct Mechanisms: the TAK1/JNK1 Signaling Cascade and Caspase Inhibition , 2002, Molecular and Cellular Biology.
[27] J. Trapani,et al. Initiation of Apoptosis by Granzyme B Requires Direct Cleavage of Bid, but Not Direct Granzyme B–Mediated Caspase Activation , 2000, The Journal of experimental medicine.
[28] J. Trent,et al. Increased chromosome 20 copy number detected by fluorescence in situ hybridization (FISH) in malignant melanoma , 1997, Genes, chromosomes & cancer.
[29] W. Hahn,et al. The telomerase catalytic subunit is a widely expressed tumor-associated antigen recognized by cytotoxic T lymphocytes. , 1999, Immunity.
[30] E. Jaffee,et al. Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[31] M. Mihm,et al. Tumor infiltrating lymphocytes in lymph node melanoma metastases: a histopathologic prognostic indicator and an expression of local immune response. , 1996, Laboratory investigation; a journal of technical methods and pathology.
[32] G M Kasof,et al. Livin, a Novel Inhibitor of Apoptosis Protein Family Member* , 2001, The Journal of Biological Chemistry.
[33] F. Alt,et al. Mechanism and control of class-switch recombination. , 2002, Trends in immunology.
[34] J C Reed,et al. IAP family proteins--suppressors of apoptosis. , 1999, Genes & development.
[35] E. Jaffee,et al. Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens. , 1994, Science.
[36] D. Neuberg,et al. ATP6S1 elicits potent humoral responses associated with immune-mediated tumor destruction , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[37] T. Hercend,et al. A MAGE‐6‐encoded peptide is recognized by expanded lymphocytes infiltrating a spontaneously regressing human primary melanoma lesion , 1999, European journal of immunology.
[38] M. Mihm,et al. Differences in dendritic cells stimulated in vivo by tumors engineered to secrete granulocyte-macrophage colony-stimulating factor or Flt3-ligand. , 2000, Cancer research.
[39] G. Salvesen,et al. ML-IAP, a novel inhibitor of apoptosis that is preferentially expressed in human melanomas , 2000, Current Biology.
[40] D. Green,et al. Granzyme B–Mediated Cytochrome C Release Is Regulated by the Bcl-2 Family Members Bid and Bax , 2000, The Journal of experimental medicine.